Is Peptide Safe?
Home › Peptides › BPC-157

Is BPC-157 safe?

Unapproved
BPC-157 is not an approved drug anywhere we could find. Almost everything claimed for it comes from animal studies, with very little human data, and its US compounding status is in flux in 2026.
Not approved for human use by the FDA or Health Canada. The human evidence is limited, animal-only, or absent. Material sold outside regulated channels also has no verified identity, purity or stability, which is a separate risk from the molecule itself.

Updated October 2026 · Checked against PubMed Central, FDA, ABC News (secondary), AJMC (secondary), World Anti-Doping Agency, Health Canada (Drug Product Database)

Name
BPC-157
Also known as
Body Protection Compound-157, PL 14736
Class
Synthetic peptide (15 amino acids)
Verdict
Unapproved Not approved; evidence thin or absent
Human evidence
Animal-only
Updated
October 2026

What is BPC-157?

BPC-157 is a laboratory-made chain of 15 amino acids, originally derived from a protein found in stomach fluid. It is popular among athletes and in wellness circles for tendon, joint and gut healing. It is not sold as an approved medicine in the United States or Canada, and products offered online are usually labelled as research chemicals.

What it is claimed to do

These are the uses BPC-157 is promoted for. Listing a claim is not endorsing it — the next section is where each one meets the evidence.

What the human evidence shows

Evidence: Animal-onlyStudied in animals or in cell culture, with no completed trial in humans. Animal results routinely fail to reproduce in people, so this level supports no human conclusion at all.

A 2025 systematic review in the HSS Journal (Vasireddi and colleagues) identified 544 records and included 36 studies on BPC-157 in orthopaedic sports medicine: 35 were preclinical (animal or laboratory) and 1 was clinical. The one clinical study was a retrospective review of 12 patients who received injections for chronic knee pain, 7 of whom reported symptom improvement lasting more than 6 months. The authors concluded that BPC-157 shows promise in preclinical work, that human evidence is limited, and that no clinical safety data were found. Animal results do not reliably predict results in people.

Known risks and side effects

Regulatory status as of October 2026. Approval, prescription status and compounding restrictions change without notice, and the two countries move independently. Check the regulator directly before relying on any of it.

United States

Approved for human use
No — not approved by the FDA for any human use
Prescription only
Not applicable or not yet determined

Not FDA approved. The FDA's list of bulk drug substances shows BPC-157 among substances nominated for compounding and then withdrawn; the agency cites limited safety data. On July 23, 2026 the FDA's Pharmacy Compounding Advisory Committee voted 8 to 6 to recommend adding BPC-157 to the list of bulk substances that licensed pharmacies may compound, against the written advice of FDA staff. The vote is advisory and non-binding. On October 29, 2026 HHS announced a draft enforcement-discretion policy that would let state-licensed pharmacies and physicians compound BPC-157 acetate under conditions while the FDA works through rulemaking. HHS and the FDA both state this is not an approval and does not mean the product has been reviewed for safety or effectiveness. A prescription would still be required, and comments on the draft are open.

Canada

Approved for human use
No — not approved by Health Canada for any human use
Prescription only
Not applicable or not yet determined

We found no Health Canada authorization for BPC-157 as a drug. Products sold online as research chemicals are not authorized for human use. You can check the Drug Product Database for any authorized product.

Who should avoid BPC-157

Frequently asked questions

Is BPC-157 safe?

Nobody can say yet. Reviewers found no clinical safety data, and the FDA cites limited safety information, immunogenicity risk and impurity concerns. The promising findings come mostly from animal studies.

Is BPC-157 legal?

It is not an approved drug in the US or, as far as we found, in Canada. Its US compounding status is changing: an advisory vote in July 2026 and an HHS draft enforcement policy in October 2026 point toward limited pharmacy compounding with a prescription, but neither is an approval and the policy is still a draft.

Does BPC-157 work for tendon injuries?

There is not enough human evidence to say. The only clinical study in a 2025 systematic review involved 12 patients without a control group. Standard rehabilitation approaches remain the evidence-based option.

Sources

Browse all 16 peptides →

Educational information only. This page summarises published evidence and regulatory records about BPC-157. It is not medical advice, it is not a recommendation for or against use, and it cannot account for your history, medications or conditions — that is a conversation for a licensed clinician.We sell nothing, name no seller, and carry no affiliate or vendor links. See the full disclaimer and ourmethodology.